Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
Ferguson
FERG
|
+$106M |
| 3 |
Apple
AAPL
|
+$103M |
| 4 |
Amazon
AMZN
|
+$103M |
| 5 |
Tesla
TSLA
|
+$75.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$51.9M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$36.1M |
| 5 |
Equity Residential
EQR
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.9% |
| 2 | Healthcare | 14.3% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Communication Services | 10.98% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Applied Industrial Technologies
AIT
$13B
| $8.08M | 0.01% |
88,600
+900
| +1% | +$76.4K |
|
1127
Diodes
DIOD
$4.48B
| $8.07M | 0.01% |
101,100
+1,500
| +2% | +$119K |
|
1128
Blackbaud
BLKB
$2.1B
| $8.05M | 0.01% |
113,253
+1,200
| +1% | +$82.8K |
|
1129
Rogers Corp
ROG
$2.48B
| $8.04M | 0.01% |
42,700
+400
| +0.9% | +$71.4K |
|
1130
Hain Celestial
HAIN
$53.9M
| $8.04M | 0.01% |
184,314
| – | – |
|
1131
Dana Inc
DAN
$3.26B
| $8.03M | 0.01% |
330,200
+2,700
| +0.8% | +$61.9K |
|
1132
SPS Commerce
SPSC
$2.86B
| $8.01M | 0.01% |
80,700
+1,300
| +2% | +$137K |
|
1133
Veracyte
VCYT
$3.42B
| $8.01M | 0.01% |
149,100
+20,900
| +16% | +$1.2M |
|
|
STAY
1134
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $8.01M | 0.01% |
405,686
+3,400
| +0.8% | +$55.5K |
|
1135
Credit Acceptance
CACC
$6.05B
| $7.99M | 0.01% |
22,177
+200
| +0.9% | +$72.5K |
|
|
ALE
1136
DELISTED
Allete
ALE
| $7.98M | 0.01% |
118,800
+1,400
| +1% | +$91.7K |
|
1137
FormFactor
FORM
$10.3B
| $7.97M | 0.01% |
176,800
+2,600
| +1% | +$118K |
|
|
ISBC
1138
DELISTED
Investors Bancorp, Inc.
ISBC
| $7.97M | 0.01% |
542,476
+5,700
| +1% | +$73.7K |
|
|
BHVN
1139
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $7.96M | 0.01% |
116,500
+1,800
| +2% | +$146K |
|
1140
Iovance Biotherapeutics
IOVA
$2.95B
| $7.96M | 0.01% |
251,356
+3,000
| +1% | +$124K |
|
1141
Ambarella
AMBA
$3.6B
| $7.94M | 0.01% |
79,133
+1,300
| +2% | +$142K |
|
1142
EPR Properties
EPR
$4.7B
| $7.94M | 0.01% |
170,488
+1,800
| +1% | +$75.9K |
|
1143
Qualys
QLYS
$6.47B
| $7.94M | 0.01% |
75,800
+400
| +0.5% | +$44.8K |
|
1144
Cardlytics
CDLX
$25.1M
| $7.93M | 0.01% |
7,230
+1,680
| +30% | +$2.22M |
|
1145
Insmed
INSM
$28.9B
| $7.93M | 0.01% |
232,700
+3,300
| +1% | +$126K |
|
1146
Ormat Technologies
ORA
$6.97B
| $7.93M | 0.01% |
100,934
+8,400
| +9% | +$832K |
|
1147
AMN Healthcare
AMN
$1.34B
| $7.92M | 0.01% |
107,500
+1,300
| +1% | +$96.6K |
|
1148
Ameris Bancorp
ABCB
$6B
| $7.92M | 0.01% |
150,744
+1,200
| +0.8% | +$57K |
|
1149
Meritage Homes
MTH
$4.8B
| $7.91M | 0.01% |
172,000
+1,800
| +1% | +$78K |
|
1150
LiveRamp
RAMP
$2.3B
| $7.86M | 0.01% |
151,500
+2,600
| +2% | +$177K |
|
Similar funds
Swiss National Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Swiss National Bank held 2,502 positions worth $150B, up 6.6% from $141B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 1.3%. Swiss National Bank opened 12 new positions and exited 20, leaving the 2,502-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q1 2021 buy was Ferguson: 872,392 shares worth $104M.
- Swiss National Bank added most to Microsoft in Q1 2021, an estimated $111M increase.
- Swiss National Bank's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $51.9M.
- Swiss National Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $96.7M.
- Swiss National Bank's ten largest holdings make up 23% of its $150B portfolio in Q1 2021.
- Swiss National Bank opened 12 new positions and closed 20 in Q1 2021.
- Swiss National Bank's portfolio value rose 6.6% quarter-over-quarter to $150B.
Based on Swiss National Bank's 13F filing for Q1 2021, filed 7 May 2021.